This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Congenital haemangioma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

These are rare vascular tumours that are fully developed at birth in contrast to the common infantile haemangiomas (such as superficial infantile haemangioma e.g. strawberry naevus type). They do not grow disproportionately to the infant's growth.

The incidence of congenital haemangiomas does not differ according to sex.

The tumours average about 5-6 cm in diameter at birth (1).

Two types are recognised (1):

  • rapidly involuting congenital haemangioma (RICH)
    • regresses around 10-14 months of age. It is a protuberant, hemispherical, violaceous tumour that often has a central depression, scar, or ulceration
  • noninvoluting congenital haemangioma (NICH)
    • never regresses, grows proportionately with the child and has fast-flow characteristics. It is well-circumscribed, plaque-like, or slightly bossed with telangiectasia and often has a central or peripheral pallor.
  • GLUT-1 is negative in both (1) - in contrast to the high positivity seen in infantile haemangiomas.

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.